You have 9 free searches left this month | for more free features.

Unknown Primary Squamous Cell Carcinoma

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
    • (no location specified)
    Aug 17, 2023

    Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

    Not yet recruiting
    • Squamous Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Jun 23, 2023

      Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node

      Recruiting
      • Squamous Cell Carcinoma
      • +2 more
      • sentinel lymph node biopsy (SLNB)
      • Indianapolis, Indiana
        Indiana University Melvin & Bren Simon Cancer Center
      Nov 15, 2022

      Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

      Recruiting
      • Metastatic Esophageal Squamous Cell Carcinoma
      • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors(Sintilimab)
      • Qingdao, Shandong, China
      • +1 more
      Nov 13, 2023

      Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • no intervention
      • Wuhan, Hubei, China
        Renmin hosptial of Wuhan University
      Jul 29, 2023

      Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

      Not yet recruiting
      • Minimal Residual Disease
      • Esophageal Squamous Cell Carcinoma
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Jun 10, 2023

        Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

        Not yet recruiting
        • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
        • Guangzhou, Guangdong, China
          Sun Yat-sen University
        Oct 24, 2023

        Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
        • (no location specified)
        Mar 17, 2023

        Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Skin
        • Carrilizumab with albumin-binding paclitaxel
        • Zhengzhou, Henan, China
          Henan Cancer Hospital
        May 23, 2023

        Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 30, 2023

        Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

        Not yet recruiting
        • Locally Advanced Head and Neck Squamous Cell Carcinoma
        • (no location specified)
        Mar 20, 2023

        Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Intensity-modulated radiotherapy (IMRT)
        • +3 more
        • Wuhan, Hubei, China
          Renmin hosptial of Wuhan University
        Jun 16, 2023

        Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Aug 17, 2023

        Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Carrilizumab, bevacizumab,capecitabine
        • (no location specified)
        Jul 20, 2023

        Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

        Not yet recruiting
        • Cutaneous Squamous Cell Carcinoma
        • (no location specified)
        May 24, 2023

        Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • PET/CT
        • Neck dissection
        • (no location specified)
        Jan 31, 2023

        The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

        Recruiting
        • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
        • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
        • Hanzhou, Zhejiang, China
          Lulu Liu
        Jul 14, 2023

        Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

        Active, not recruiting
        • Squamous Cell Carcinoma of the Oropharynx
        • +7 more
        • Tampa, Florida
        • +2 more
        Dec 30, 2022

        Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

        Recruiting
        • Oral Squamous Cell Carcinoma
        • Oral Mucositis
        • Alfacalcidol Oral Solution
        • Placebo
        • Guangzhou, Guangdong, China
          Sun Yat-sen Memorial Hospital
        Aug 24, 2023

        Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

        Not yet recruiting
        • Oral Squamous Cell Carcinoma
        • Neck Dissection
        • Elective neck dissection
        • Therapeutic neck dissection
        • (no location specified)
        Apr 10, 2023

        Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

        Not yet recruiting
        • Advanced Esophageal Squamous Carcinoma With Oligometastases
        • simultaneous with radiotherapy
        • synchronous with radiotherapy
        • (no location specified)
        Nov 16, 2023

        Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Locally Advanced Operable
        • Guangzhou, Guangdong, China
        • +1 more
        Sep 4, 2023

        Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
          • Hangzhou, Zhejiang, China
            Second Affiliated Hospital, School of Medicine, Zhejiang Univers
          Aug 22, 2023